You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

AZCT

Cancer Type: Hematologic, Leukemia - Acute Myeloid (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms (MPNs)      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
New Drug Funding Program
    Azacitidine - Intermediate-2 and high-risk myelodysplastic syndrome (MDS)
New Drug Funding Program
    Azacitidine - Acute Myeloid Leukemia (AML)

You might also be interested in